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A B S T R A C T
Age-related EBV-associated B-cell lymphoproliferative disorders (AEBVLPD) was incorporated into the 2008
World Health Organization classiﬁcation of lymphomas as Epstein-Barr virus (EBV)-positive diffuse large
B-cell lymphoma of the elderly. This disease is deﬁned as a histologically malignant polymorphic or mono-
morphic B-cell lymphoproliferation in patients more than 50 years of age without any known immuno-
deﬁciency or prior lymphoma. These patients have been reported to have a worse prognosis than those
with EBV-negative diffuse large B-cell lymphoma or EBV-positive Hodgkin lymphoma. Here we describe
a case of age-related EBV-associated B-cell lymphoproliferative disorder arising in the minor salivary gland,
which is a disease that has rarely been reported in the oral and maxillofacial regions. This case report is
on a patient who also had a history of remitting seronegative symmetrical synovitis with pitting edema
syndrome and had been administrated low-dose prednisolone.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Lymphoma is the secondmost commonmalignant disease in the
head and neck after squamous cell carcinoma [1]. The head and neck
region has also been reported as the second most frequent site of
extranodal lymphomas after the gastrointestinal tract [2]. Whereas
Waldeyer’s ring contains almost half of the extranodal lympho-
mas of the head and neck, that of the oral cavity is less common
[3]. As for salivary gland lymphoma, the parotid gland is the most
commonly affected site followed by the submandibular, sublin-
gual, and minor salivary glands [4–6]. The World Health Organiza-
tion classiﬁcation system for neoplastic diseases of the hematopoietic
and lymphoid tissues is currently the most commonly used system
for the classiﬁcation of malignant lymphoma [7]. The World Health
Organization updated this classiﬁcation in 2008, recognizing several
diffuse large B-cell lymphoma (DLBCL) entities characterized by the
Epstein-Barr virus (EBV). One of them is age-related EBV-associated
B-cell lymphoproliferative disorders (AEBVLPD), which is deﬁned
as a histologically malignant polymorphic or monomorphic B-cell
lymphoproliferation in patients more than 50 years of age without
any known immunodeﬁciency or prior lymphoma [8,9]. Here we
describe a case of AEBVLPD arising in theminor salivary gland, which
is a disease that has rarely been reported in the oral and maxillo-
facial regions.
2. Presentation of case
An 80-year-old woman noticed amass in her right cheek. Because
there was no pain, the patient did not seek any medical assistance
for 5 months. She consulted a physician during a routine follow-
up for her medical condition and was subsequently referred to our
hospital for examination and treatment of her cheek. Her medical
history included remitting seronegative symmetrical synovitis with
pitting edema (RS3PE) syndrome and breast cancer fromwhich she
had been disease free for 7 years after surgical treatment.
On clinical examination, there was a mass measuring approxi-
mately 10 × 10 mm in the right cheek (Figure 1A). No lymphade-
nopathy was observed in the neck.
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An ultrasound displayed a round-shaped and well-deﬁned
hypoechoic mass of 10 × 12 mm lying under the buccal mucosa
(Figure 1B). A T2-weighted short tau inversion recovery (STIR) mag-
netic resonance image depicted high-intensity areas in the right
cheek (Figure 1C).
A tentative diagnosis of theminor salivary gland tumorwasmade,
and surgical excision was performed to conﬁrm the diagnosis de-
ﬁnitively (Figure 2). On microscopic examination of the surgical
specimen, the minor salivary gland, as well as the area around the
salivary duct, demonstrated abscess formation with diffuse inﬁl-
tration of lymphocytes (Figure 3A). The surgical specimen also re-
vealed components of various reactive elements such as plasma cells,
histiocytes, and small lymphocytes. Reed-Sternberg-like cells were
also shown on the slide (Figure 3B). Immunohistochemical analy-
sis revealed that many lymphoid cells were positive for CD20 but
negative for CD30 (Figure 3C). Because only a small number of cells
expressed CD15, we conﬁrmed this as negative. Epstein-Barr nuclear
antigen 2 (EBNA2) and latent membrane protein 1 also had nega-
tive expressions (data not shown). In situ hybridization for EBV-
encoded small RNA showed positive cells in the specimen, which
conﬁrmed the presence of EBV (Figure 3D). Based on these ﬁnd-
ings, histologic evaluation showed the surgical specimen was com-
patible with AEBVLPD.
The patient was referred to the hematology department for
further systemic workup, and then no other lesions were ob-
served. To date, the patient continues to show no evidence of disease
recurrence and is being carefully followed up.
3. Discussion
AEBVLPD has a broad morphologic spectrum ranging from the
reactive proliferation of lymphoid cells to DLBCL, and the differen-
tial diagnosis especially between EBV-positive Hodgkin lym-
phoma and AEBVLPD is sometimes diﬃcult [9–11]. The current case
demonstrated the presence of a background of reactive compo-
nents such as plasma cells, histiocytes, and small lymphocytes, as
well as Reed-Sternberg-like cells on microscopic examination.
These histopathologic ﬁndings are involved in both AEBVLPD
and EBV-positive Hodgkin lymphoma. One of the distinctions
between them is to recognize B-cell markers such as CD20 or
CD79a showing positive expression in AEBVLPD [9]. EBNA2 and CD15
are also useful for diagnosing AEBVLPD and EBV-positive Hodgkin
lymphoma using immunohistochemical analysis [11]. We found a
positive expression for CD20, contrasted with a negative expres-
sion for CD15, indicating the case was of B-cell lineage. Regarding
the expression of EBNA2, the case was negative. However, EBV-
encoded small RNA demonstrated a positive expression, showing
that the case was EBV-related. A previous article also indicated
that CD30 stein cells were more common in AEBVLPD than in
EBV-negative DLBCL. However, the current case displayed a nega-
tive expression [12].
Geographic necrosis was found in reportedly 55% of AEBVLPD
cases [9,11]. Although the current case did not demonstrate this
ﬁnding either clinically or histologically, microscopic examination
revealed an abscess formation.
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Figure 1. (A) Intraoral photograph of the patient demonstrates the mass in the right buccal submucosa (black arrow). (B) Intraoral ultrasound image displays the hypoechoic
mass lying under the buccal mucosa. (C) This lesion in the right cheek is depicted as a high signal intensity area on T2-weighted short tau inversion recovery (STIR) mag-
netic resonance image.
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Figure 2. (A) Intraoral photograph of the patient shows a resection margin at the time of the surgery (dotted line). (B) The buccinator muscle was exposed after surgical
resection. (C) The surgical specimen is depicted, measuring approximately 14 × 11 mm. (D) Serial cut surfaces of formalin-ﬁxed specimen demonstrates a solid mass in the
surrounding tissue.
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Figure 3. (A) Histologic feature of the surgical specimen showed an abscess formation but not necrosis or blood vessel distractions in the minor salivary gland, which in-
volved a diffuse proliferation of lymphoid cells (hematoxylin and eosin [H&E] stain, original magniﬁcation ×40). (B) Hodgkin and Reed-Sternberg-like cells were observed
scattered among reactive cells. Large atypical lymphoid cells with irregular nuclei were also observed in the specimen (H&E stain, original magniﬁcation ×400). (C) Immu-
nohistochemical ﬁndings of the surgical specimen demonstrated a CD20 expression in these cells (original magniﬁcation ×400). (D) In situ hybridization showed an Epstein-
Barr virus-encoded small RNA expression in the nuclei of the cells (original magniﬁcation ×400).
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AEBVLPD has been reported to have an association with
immunosenescence as a part of the aging process. On the other hand,
immunodeﬁciency-associated lymphoproliferative disorder (LPD)
includes associations with primary immunodeﬁciency syndromes
or other primary immune disorders, HIV infection, iatrogenic
posttransplantation immunosuppression, and administration of
methotrexate, which is most commonly seen in patients with au-
toimmune disease [8,9]. The current case had a history of RS3PE
syndrome and had been administrated low-dose prednisolone for
9 months at the time of the ﬁrst visit to our hospital. RS3PE pa-
tients are usually given a low-dose steroid to which they usually
show positive response, as depicted in previous reports in which
it was administrated [13–15]. One of the main points in diagnos-
ing LPD in the current case was whether or not the prednisolone
caused immunosuppression which developed into LPD. The patient
had been placed on a 15-mg daily dose of prednisolone for 4months
before the mass was noticed. However, we did not believe that this
dose and duration of prednisolone administration was enough to
cause immunosuppression and subsequent development of LPD, and
therefore we conﬁrmed the current case to be AEBVLPD.
RS3PE syndrome also has been reported to be associated with
the underlying malignancy, especially in the presence of poor thera-
peutic response to steroids [13,16]. Although the administration of
steroids did not seem to relate with the development of the LPD,
RS3PE itself still has the possibility of being a pathogenesis of LPD.
Previous articles have indicated that the prognosis and treat-
ment outcome of AEBVLPD were signiﬁcantly poorer than those
of EBV-associated DLBCL [10–12]. Of note, it has been shown that
patients over 70 years old and patients with B symptoms were
both signiﬁcant prognostic factors in multivariate analysis [12]. Con-
sidering the current patient’s age of 80 years, careful follow-up
should be required, even though no B symptoms were observed.
Moreover, based on the International Prognostic Index, which has
also been reported to have a prognostic value, the current patient
met with two risk factors: (1) age higher than 60 years and (2) a
performance status of more than 2, demonstrating the risk cat-
egory was low-intermediate. In addition, it has been mentioned
that the prognosis of AEBVLPD was signiﬁcantly inﬂuenced by the
host immune status [12]. As we described, the current case did
not seem to be in immunosuppression. However, the inﬂuence of
steroid administration should be reconsidered for further follow-
up of RS3PE.
To date, the patient has been making steady progress with both
AEBVLPD and RS3PE. However, careful observation is needed because
of the possibility of recurrent LPDs or new lesions, as well as wors-
ening of RS3PE.
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